» Articles » PMID: 11773447

Hepatic Nuclear Factor-3 (HNF-3 or Foxa2) Regulates Glucagon Gene Transcription by Binding to the G1 and G2 Promoter Elements

Overview
Journal Mol Endocrinol
Date 2002 Jan 5
PMID 11773447
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Glucagon gene expression in the endocrine pancreas is controlled by three islet-specific elements (G3, G2, and G4) and the alpha-cell-specific element G1. Two proteins interacting with G1 have previously been identified as Pax6 and Cdx2/3. We identify here the third yet uncharacterized complex on G1 as hepatocyte nuclear factor 3 (HNF-3)beta, a member of the HNF-3/forkhead transcription family, which plays an important role in the development of endoderm-related organs. HNF-3 has been previously demonstrated to interact with the G2 element and to be crucial for glucagon gene expression; we thus define a second binding site for this transcription on the glucagon gene promoter. We demonstrate that both HNF-3alpha and -beta produced in heterologous cells can interact with similar affinities to either the G1 or G2 element. Pax6, which binds to an overlapping site on G1, exhibited a greater affinity as compared with HNF-3alpha or -beta. We show that both HNF-3beta and -alpha can transactivate glucagon gene transcription through the G2 and G1 elements. However, HNF-3 via its transactivating domains specifically impaired Pax6-mediated transactivation of the glucagon promoter but had no effect on transactivation by Cdx2/3. We suggest that HNF-3 may play a dual role on glucagon gene transcription by 1) inhibiting the transactivation potential of Pax6 on the G1 and G3 elements and 2) direct activation through G1 and G2.

Citing Articles

A noncoding variant confers pancreatic differentiation defect and contributes to diabetes susceptibility by recruiting RXRA.

Li Y, Zheng R, Jiang L, Yan C, Liu R, Chen L Nat Commun. 2024; 15(1):9771.

PMID: 39532884 PMC: 11557932. DOI: 10.1038/s41467-024-54151-y.


The role of FOXA family transcription factors in glucolipid metabolism and NAFLD.

Yu C, Li X, Zhao Y, Hu Y Front Endocrinol (Lausanne). 2023; 14:1081500.

PMID: 36798663 PMC: 9927216. DOI: 10.3389/fendo.2023.1081500.


Profiling of RNA-binding Proteins Interacting With Glucagon and Adipokinetic Hormone mRNAs.

Ko S, Yeom E, Chun Y, Mun H, Howard-McGuire M, Millison N J Lipid Atheroscler. 2022; 11(1):55-72.

PMID: 35118022 PMC: 8792818. DOI: 10.12997/jla.2022.11.1.55.


Glucagon's Metabolic Action in Health and Disease.

Zeigerer A, Sekar R, Kleinert M, Nason S, Habegger K, Muller T Compr Physiol. 2021; 11(2):1759-1783.

PMID: 33792899 PMC: 8513137. DOI: 10.1002/cphy.c200013.


Aberrant development of pancreatic beta cells derived from human iPSCs with FOXA2 deficiency.

Elsayed A, Younis I, Ali G, Hussain K, Abdelalim E Cell Death Dis. 2021; 12(1):103.

PMID: 33473118 PMC: 7817686. DOI: 10.1038/s41419-021-03390-8.